Patient-reported toxic effects of hypofractionated versus conventional RT

Affiliations

Comparative Study

Maria Chiara Masone. Nat Rev Urol. 2024 May.

. 2024 May;21(5):257.

doi: 10.1038/s41585-024-00883-x.

No abstract available

Comment on

Noninferiority of Hypofractionated vs Conventional Postprostatectomy Radiotherapy for Genitourinary and Gastrointestinal Symptoms: The NRG-GU003 Phase 3 Randomized Clinical Trial.
Buyyounouski MK, Pugh SL, Chen RC, Mann MJ, Kudchadker RJ, Konski AA, Mian OY, Michalski JM, Vigneault E, Valicenti RK, Barkati M, Lawton CAF, Potters L, Monitto DC, Kittel JA, Schroeder TM, Hannan R, Duncan CE, Rodgers JP, Feng F, Sandler HM. Buyyounouski MK, et al. JAMA Oncol. 2024 May 1;10(5):584-591. doi: 10.1001/jamaoncol.2023.7291. JAMA Oncol. 2024. PMID: 38483412 Free PMC article. Clinical Trial.

1. Buyyounouski, M. K. et al. Noninferiority of hypofractionated vs conventional postprostatectomy radiotherapy for genitourinary and gastrointestinal symptoms. JAMA Oncol. https://doi.org/10.1001/jamaoncol.2023.7291 (2024) - DOI - PubMed